Clinicopathologic features and survival in fibrolamellar carcinoma: Comparison with conventional hepatocellular carcinoma with and without cirrhosis

Modern Pathology

Volumn 18, Issue 11, 2005, Pages 1417-1423

  Kakar, Sanjay ^a   Burgart, Lawrence J ^b   Batts, Kenneth P ^c   Garcia, Joaquin ^a   Jain, Dhanpat ^d   Ferrell, Linda D ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b MAYO CLINIC   (United States)

^c ABBOTT NORTHWESTERN HOSPITAL   (United States)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cirrhosis; Fibrolamellar; Hepatocellular carcinoma; Survival

Indexed keywords

KI 67 ANTIGEN;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL; SEX RATIO; TUMOR VOLUME;

ADOLESCENT; ADULT; CARCINOMA, HEPATOCELLULAR; CELL PROLIFERATION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; SURVIVAL ANALYSIS; SURVIVAL RATE;

EID: 27144486411     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.3800449     Document Type: Article

References (36)

1. Craig JR, Peters RL, Edmondson HA, et al. Fibrolamellar carcinoma of the liver: a tumor of adolescents and young adults with distinctive clinico-pathologic features. Cancer 1980;46:372-379.
2. Ruffin IV MT. Fibrolamellar hepatoma. Am J Gastroenterol 1990;85:577-581.
3. El-Serag HB, Davila JA. Is fibrolamellar carcinoma different from hepatocellular carcinoma? A US population-based study. Hepatology 2004;39:798-803.
4. Hodgson HJ. Fibrolamellar cancer of the liver. J Hepatol 1987;5:241-247.
5. Berman MA, Burnham JA, Sheahan DG. Fibrolamellar carcinoma of the liver: an immunohistochemical study of nineteen cases and a review of the literature. Hum Pathol 1988;19:784-794.
6. Ringe B, Wittekind C, Weimann A, et al. Results of hepatic resection and transplantation for fibrolamellar carcinoma. Surg Gynecol Obstet 1992;175:299-305.
7. Burgart LJ, Martinez CJM, Batts KP. Fibrolamellar hepatoma - importance of using a strict definition (abstract). Mod Pathol 1994;7:129A.
8. Lack EE, Neave C, Vawter GF. Hepatocellular carcinoma. Review of 32 cases in childhood and adolescence. Cancer 1983;52:1510-1515.
9. Farhi DC, Shikes RH, Murari PJ, et al. Hepatocellular carcinoma in young people. Cancer 1983;52:1516-1525.
10. Starzl TE, Iwatsuki S, Shaw Jr BW, et al. Treatment of fibrolamellar hepatoma with partial or total hepatectomy and transplantation of the liver. Surg Gynecol Obstet 1986;162:145-148.
11. Soreide O, Czerniak A, Bradpiece H, et al. Characteristics of fibrolamellar hepatocellular carcinoma. A study of nine cases and a review of the literature. Am J Surg 1986;151:518-523.
12. Wood WJ, Rawlings M, Evans H, et al. Hepatocellular carcinoma: importance of histologic classification as a prognostic factor. Am J Surg 1988;155:663-666.
13. Okuda K. Natural history of hepatocellular carcinoma including fibrolamellar and hepato-cholangiocarcinoma variants. J Gastroenterol Hepatol 2002;17:401-405.
14. Pinna AD, Iwatsuki S, Lee RG, et al. Treatment of fibrolamellar hepatoma with subtotal hepatectomy or transplantation. Hepatology 1997;26:877-883.
15. Everson GT, Trotter JF. Transplantation of the liver. In: Schiff ER, Sorrell MF, Maddrey WC (eds). Diseases of the Liver, 9th edn., Vol. 2. Lippincott, Williams and Wilkins: Philadelphia, 2003, pp 1585-1614.
16. Sherlock S, Dooley J (eds). Malignant liver tumors. In: Diseases of the Liver and Biliary System, 11th edn. Blackwell Science: Malden, MA, 2003, pp 537-562.
17. Rosai J. Rosai and Ackerman's Surgical Pathology. Mosby: Philadelphia, 9th edn., Vol. 1. 2004, pp 1001-1002.
18. Ferrell LD. Benign and malignant tumors of the liver. In: Odze RD, Goldblum JR, Crawford JM (eds). Surgical Pathology of the GI Tract, Liver, Biliary Tract and Pancreas. Saunders: Philadelphia, 2004, pp 1012.
19. Nagorney DM, Adson MA, Weiland LH, et al. Fibrolamellar hepatoma. Am J Surg 1985;149:113-119.
20. Haas JE, Muczynski KA, Krailo M, et al. Histopathology and prognosis in childhood hepatoblastoma and hepatocarcinoma. Cancer 1989;64:1082-1095.
21. Katzenstein HM, Krailo MD, Malogolowkin MH, et al. Fibrolamellar hepatocellular carcinoma in children and adolescents. Cancer 2003;97:2006-2012.
22. Hamilton SR, Aaltonen LA (eds). Tumors of the liver and intrahepatic bile ducts. In: Pathology and Genetics of the Digestive System. IARC Press: Lyon, 2000, pp 159-172.
23. Chedid A, Ryan LM, Dayal Y, et al. Morphology and other prognostic factors of hepatocellular carcinoma. Arch Pathol Lab Med 1999;123:524-528.
24. Quaglia A, Bhattacharjya S, Dhillon AP. Limitations of the histopathological diagnosis and prognostic assessment of hepatocellular carcinoma. Histopathology 2001;38:167-174.
25. Monto A, Wright TL. The epidemiology and prevention of hepatocellular carcinoma. Semin Oncol 2001;28:441-449.
26. Vecchio FM, Federico F, Dina MA. Copper and hepatocellular carcinoma. Digestion 1986;35:109-114.
27. Lefkowitch JH, Muschel R, Price JB, et al. Copper and copper-binding protein in fibrolamellar liver cell carcinoma. Cancer 1983;51:97-100.
28. Guigui B, Mavier P, Lescs MC, et al. Copper and copper-binding protein in liver tumors. Cancer 1988;61:1155-1158.
29. Garcia de Davila MT, Gonzalez-Crussi F, Mangkornkanok M. Fibrolamellar carcinoma of the liver in a child: ultrastructural and immunohistologic aspects. Pediatr Pathol 1987;7:319-331.
30. Wang JH, Dhillon AP, Sankey EA, et al. 'Neuroendocrine' differentiation in primary neoplasms of the liver. J Pathol 1991;163:61-67.
31. Caballero T, Aneiros J, Lopez-Caballero J, et al. Fibrolamellar hepatocellular carcinoma. An immunohistochemical and ultrastructural study. Histopathology 1985;9:445-456.
32. Zhao M, Laissue JA, Zimmermann A. 'Neuroendocrine' differentiation in hepatocellular carcinomas (HCCs): immunohistochemical reactivity is related to distinct tumor cell types, but not to tumor grade. Histol Histopathol 1993;8:617-626.
33. Huang XF, Wang CM, Dai XW, et al. Expressions of chromogranin A and cathepsin D in human primary hepatocellular carcinoma. World J Gastroenterol 2000;6:693-698.
34. Orsatti G, Greenberg PD, Rolfes DB, et al. DNA ploidy of fibrolamellar hepatocellular carcinoma by image analysis. Hum Pathol 1994;25:936-939.
35. Wilkens L, Bredt M, Flemming P, et al. Cytogenetic aberrations in primary and recurrent fibrolamellar hepatocellular carcinoma detected by comparative genomic hybridization. Am J Clin Pathol 2000;114:867-874.
36. Okada K, Kim YI, Nakashima K, et al. Fibrolamellar hepatocellular carcinoma coexistent with a hepatocellular carcinoma of common type: report of a case. Surg Today 1993;23:626-631.